Martin Voss
Physician · Memorial Hospital for Cancer and allied Diseases
Credentials: · · ·
History
- 2005–2008
- 2001–2005
Albert-Ludwig University Freiburg
Research
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
OncoKB: A Precision Oncology Knowledge Base
JCO Precision Oncology · 2017 · 2,318 citations
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Science · 2018 · 999 citations
- RM
98 papers

64 papers · 17 as a resident
- RK
45 papers · 14 as a fellow
- PR
44 papers

40 papers
- CL
39 papers
- MC
38 papers · 2 as a fellow

34 papers
Clinical trials
- 2025–2028
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2016–2020
Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
- 2014–2020
Principal investigator · Completed · Phase 1, Phase 2
MedImmune LLC

